Uncategorized

January 24, 2022

The Afterglow: Reflections on Phase 2 & 3 MDMA-Assisted Therapy for PTSD Trials

January 24, 2022

The Faces of Phase 3: Principal Investigators in MAPS’ Clinical Trials of MDMA-Assisted Therapy for PTSD

January 24, 2022

MDMA-assisted therapy for severe PTSD: a randomized, double-blind, placebo-controlled phase 3 study

January 24, 2022

Talk on MDMA at the Hearst Museum at UC Berkeley, June 6th, 2019, with Gregory Wells, PhD and Veronika Gold, LMFT

January 24, 2022

Altered States of Context: Dr. Gregory Wells Interview

January 24, 2022

What is Ketamine Therapy?